>Your< Iron Syrup clinical trial published

results abstract

>Your< Iron Syrup is now clinically proven to increase ferritin levels in iron-deficient children by 69%, thus enabling them to avoid anemia. The study, published in MDPI Nutrients, is the first to show anemia in iron-deficient children can be avoided through supplementation.

The trial was a randomized, double-blind, placebo-controlled intervention. It sets a high quality standard, as it was carried out in 15 research centers and on a statistically significant number of non-anemic children (85). No other trial on children’s iron deficiency is directly comparable. They are either performed on anemic subjects and/or with an iron dose that categorizes the product as a drug and not a supplement.

Products from >Your< Iron Line have been successfully launched by companies such as subsidiaries of STADA and Teva in over 20 markets. For example, a partner of ours in Europe launched >Your< Iron Line and is now selling 500.000 units per year in a market of under 20 million people. The  product line's 3 key advantages (great taste, absence of side effects, and high efficacy) have already been driving successful sales thus far. Now, the addition of the new clinical trial on >Your< Iron Syrup will improve medical detailing and further separate the products from competition.